275 related articles for article (PubMed ID: 21357255)
1. Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus.
Horton HM; Chu SY; Ortiz EC; Pong E; Cemerski S; Leung IW; Jacob N; Zalevsky J; Desjarlais JR; Stohl W; Szymkowski DE
J Immunol; 2011 Apr; 186(7):4223-33. PubMed ID: 21357255
[TBL] [Abstract][Full Text] [Related]
2. Suppression of rheumatoid arthritis B cells by XmAb5871, an anti-CD19 antibody that coengages B cell antigen receptor complex and Fcγ receptor IIb inhibitory receptor.
Chu SY; Yeter K; Kotha R; Pong E; Miranda Y; Phung S; Chen H; Lee SH; Leung I; Bonzon C; Desjarlais JR; Stohl W; Szymkowski DE
Arthritis Rheumatol; 2014 May; 66(5):1153-64. PubMed ID: 24782179
[TBL] [Abstract][Full Text] [Related]
3. Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody.
Chu SY; Horton HM; Pong E; Leung IW; Chen H; Nguyen DH; Bautista C; Muchhal US; Bernett MJ; Moore GL; Szymkowski DE; Desjarlais JR
J Allergy Clin Immunol; 2012 Apr; 129(4):1102-15. PubMed ID: 22257644
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcgammaRIIb with Fc-engineered antibodies.
Chu SY; Vostiar I; Karki S; Moore GL; Lazar GA; Pong E; Joyce PF; Szymkowski DE; Desjarlais JR
Mol Immunol; 2008 Sep; 45(15):3926-33. PubMed ID: 18691763
[TBL] [Abstract][Full Text] [Related]
5. A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling.
Li X; Wu J; Carter RH; Edberg JC; Su K; Cooper GS; Kimberly RP
Arthritis Rheum; 2003 Nov; 48(11):3242-52. PubMed ID: 14613290
[TBL] [Abstract][Full Text] [Related]
6. Through an ITIM-independent mechanism the FcγRIIB blocks B cell activation by disrupting the colocalized microclustering of the B cell receptor and CD19.
Xu L; Li G; Wang J; Fan Y; Wan Z; Zhang S; Shaheen S; Li J; Wang L; Yue C; Zhao Y; Wang F; Brzostowski J; Chen YH; Zheng W; Liu W
J Immunol; 2014 Jun; 192(11):5179-91. PubMed ID: 24790152
[TBL] [Abstract][Full Text] [Related]
7. FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling.
Kono H; Kyogoku C; Suzuki T; Tsuchiya N; Honda H; Yamamoto K; Tokunaga K; Honda Z
Hum Mol Genet; 2005 Oct; 14(19):2881-92. PubMed ID: 16115811
[TBL] [Abstract][Full Text] [Related]
8. [The abnormality of FcgammaRIIB1-mediated signaling and the hyperactivity of B cells from patients with systemic lupus erythematosus].
Peng KJ; Xiao LS; Fei Y; Wang SR
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Nov; 22(6):769-71. PubMed ID: 17077019
[TBL] [Abstract][Full Text] [Related]
9. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation.
Garaud S; Le Dantec C; Jousse-Joulin S; Hanrotel-Saliou C; Saraux A; Mageed RA; Youinou P; Renaudineau Y
J Immunol; 2009 May; 182(9):5623-32. PubMed ID: 19380809
[TBL] [Abstract][Full Text] [Related]
10. Target silencing of disease-associated B-lymphocytes by chimeric molecules in SCID model of pristane-induced autoimmunity.
Dimitrova I; Gesheva V; Nikolova K; Mihaylova N; Todorov T; Nikolova M; Tchorbanov A
Lupus; 2010 Oct; 19(11):1261-71. PubMed ID: 20530521
[TBL] [Abstract][Full Text] [Related]
11. Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb.
Cemerski S; Chu SY; Moore GL; Muchhal US; Desjarlais JR; Szymkowski DE
Immunol Lett; 2012 Mar; 143(1):34-43. PubMed ID: 22305932
[TBL] [Abstract][Full Text] [Related]
12. FcgammaRIIB, FcgammaRIIIB, and systemic lupus erythematosus.
Niederer HA; Clatworthy MR; Willcocks LC; Smith KG
Ann N Y Acad Sci; 2010 Jan; 1183():69-88. PubMed ID: 20146709
[TBL] [Abstract][Full Text] [Related]
13. Selective silencing of DNA-specific B lymphocytes delays lupus activity in MRL/lpr mice.
Tchorbanov AI; Voynova EN; Mihaylova NM; Todorov TA; Nikolova M; Yomtova VM; Chiang BL; Vassilev TL
Eur J Immunol; 2007 Dec; 37(12):3587-96. PubMed ID: 18034421
[TBL] [Abstract][Full Text] [Related]
14. Physiological up-regulation of inhibitory receptors Fc gamma RII and CR1 on memory B cells is lacking in SLE patients.
Isaák A; Gergely P; Szekeres Z; Prechl J; Poór G; Erdei A; Gergely J
Int Immunol; 2008 Feb; 20(2):185-92. PubMed ID: 18182380
[TBL] [Abstract][Full Text] [Related]
15. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E
Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
[TBL] [Abstract][Full Text] [Related]
16. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
[TBL] [Abstract][Full Text] [Related]
17. Low-level signaling generated by FcgammaRIIB-B cell receptor co-ligation establishes a state of global B cell receptor nonresponsiveness.
Preissler MT; Kaiser L; Drake JR; Gosselin EJ
Immunol Invest; 2005; 34(1):53-70. PubMed ID: 15773572
[TBL] [Abstract][Full Text] [Related]
18. B cell receptor signaling in human systemic lupus erythematosus.
Pugh-Bernard AE; Cambier JC
Curr Opin Rheumatol; 2006 Sep; 18(5):451-5. PubMed ID: 16896281
[TBL] [Abstract][Full Text] [Related]
19. The paradox of CD5-expressing B cells in systemic lupus erythematosus.
Youinou P; Renaudineau Y
Autoimmun Rev; 2007 Dec; 7(2):149-54. PubMed ID: 18035326
[TBL] [Abstract][Full Text] [Related]
20. Immune complex enhances tolerogenecity of immature dendritic cells via FcγRIIb and promotes FcγRIIb-overexpressing dendritic cells to attenuate lupus.
Zhang Y; Liu S; Yu Y; Zhang T; Liu J; Shen Q; Cao X
Eur J Immunol; 2011 Apr; 41(4):1154-64. PubMed ID: 21360699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
